semaglutide/bpc 157 acetate BPC | Gastric Pentadecapeptide K

5-Amino-1MQ for fat loss: what the science actually supports by blackdosedaily

Some drug, but probably not enough, got through – For AOD9604, large molecule size wouldn’t have reduced bioavailability to zero, and the use of polyethylene glycol as an excipient may have increased bioavailability slightly13, however there is the distinct possibility that not enough of the drug got through the gastrointestinal tract to make a therapeutic difference.” In summation: Given the stark contrast between the biohackers and the institutional scientists, we have the selective release of fats from the fat cells in obese or lean individuals (depending on who you ask) to justify using AOD-9604 for biohacking weight loss

K

Syringe:29G

Something is protecting it